We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The Global Dental Device Market to hit $12.7 Billion by 2020 Propelled by a Surge in Oral Diseases and Poor Oral Hygiene: ABMRG PR Newswire LONDON and NEW YORK, December 9, 2014 LONDON and NEW...
Linden Capital Partners Completes Acquisition of Young Innovations, Inc. /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; }...
Young Innovations Announces Shareholder Approval of Merger with Affiliates of Linden Capital Partners /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black;...
Young Innovations Announces Expiration of "Go-Shop" Period /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li...
Levi & Korsinsky is investigating the Board of Directors of Young Innovations, Inc. (“Young Innovations” or the “Company”) (NasdaqGS: YDNT) for possible breaches of fiduciary...
Young Innovations Announces Date of Special Meeting of Shareholders, Early Termination of Hart-Scott-Rodino Waiting Period and Preliminary Results of Go-Shop Process /* Style Definitions...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Young Innovations, Inc. (YDNT), Compuware Corp. (CPWR), Caribou Coffee Co. Inc. (CBOU) and Somaxon Pharmaceuticals...
Lifshitz Law Firm Announces Investigation of Caribou Coffee Company, Inc., Epoch Holding Corporation, Somaxon Pharmaceuticals, Inc. and Young Innovations, Inc. /* Style Definitions...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Intermec Inc. (IN), Somaxon Pharmaceuticals, Inc. (SOMX), Clearwire Corp. (CLWR) and Young Innovations, Inc. (YDNT) /...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions